Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03624114
What this trial is testing

Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery

Who this might be right for
Pituitary Adenoma
University Hospital, Basel, Switzerland 40
Not applicableUnknownNCT05230381
What this trial is testing

Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection

Who this might be right for
Tranexamic AcidIntraoperative Blood LossMeningioma
Beijing Tiantan Hospital 228
Testing effectiveness (Phase 2)Study completedNCT01290692
What this trial is testing

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Who this might be right for
Grade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 14
Large-scale testing (Phase 3)Study completedNCT00105937
What this trial is testing

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Who this might be right for
PainCancer
Cephalon 300
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Not applicableLooking for participantsNCT07632092
What this trial is testing

Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.

Who this might be right for
Short Time ExaminationBrain MetastasesRadiation Necrosis
Centre Hospitalier Universitaire, Amiens 50
Not applicableActive Not RecruitingNCT07447544
What this trial is testing

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

Who this might be right for
Breast CancerCentral Nervous System Metastases
Institute of Oncology Ljubljana 22
Not applicableLooking for participantsNCT04863612
What this trial is testing

SBRT in the Management of Solid Spinal Metastases

Who this might be right for
Extradural TumorSpinal Metastases
Universitaire Ziekenhuizen KU Leuven 100
Not applicableStudy completedNCT05984667
What this trial is testing

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Who this might be right for
Glioma, MixedMild Neurocognitive DisorderBrain Tumor
Virginia Commonwealth University 32
Not applicableActive Not RecruitingNCT03665064
What this trial is testing

Long Term Outcome Study in Patients With Pituitary Disorders

Who this might be right for
Pituitary DiseasesPituitary Neoplasms
University of Alberta 1,500
Testing effectiveness (Phase 2)Study completedNCT03274375
What this trial is testing

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

Who this might be right for
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris 20
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableUnknownNCT06297044
What this trial is testing

Neural and Cognitive Correlates of Pragmatic Abilities

Who this might be right for
Right Hemispheric StrokeLeft Hemispheric StrokeTraumatic Brain Injury+4 more
IRCCS San Camillo, Venezia, Italy 324
Post-approval studies (Phase 4)Study completedNCT00576472
What this trial is testing

Learning Impairments Among Survivors of Childhood Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaBrain Tumors
St. Jude Children's Research Hospital 469
Not applicableNot Yet RecruitingNCT07034365
What this trial is testing

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Fudan University 2,000
Early research (Phase 1)Study completedNCT00994071
What this trial is testing

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Who this might be right for
MedulloblastomaPontine GliomaEpendymoma+2 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT04178330
What this trial is testing

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Who this might be right for
Brain Metastases
Chinese Academy of Medical Sciences 82
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableLooking for participantsNCT04073966
What this trial is testing

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Who this might be right for
Brain MetastasesNeurocognitive DeficitWhite Matter Alterations+1 more
UNC Lineberger Comprehensive Cancer Center 20
Not applicableActive Not RecruitingNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Next Page